M&As this week: Hansa Medical, Qingdao Gon Technology

Biopharmaceutical company Hansa Medical AB, has acquired Immago Biosystems Ltd, a therapeutic antibodies developer in glycobiology.

Hansa Medical AB expects that the transaction will provide it with rights to cancer immunotherapy using antibody-modulating enzymes.

Qingdao Gon Technology has announced its plans to acquire an undisclosed pharmaceutical company.

The company expects the acquisition to cost them up to $26.59m.